PDF(Pubmed)
Abstract：
UNASSIGNED: To describe the surgical technique and report the early outcomes of the transvesical (TV) approach to single-port (SP) robot-assisted radical prostatectomy.
UNASSIGNED: All procedures were performed at a single center by one surgeon. We identified the first 100 consecutive patients with clinically localized prostate cancer that underwent SP TV robot-assisted radical prostatectomy using the da Vinci SP robotic surgical system. Data were collected prospectively and analyzed with descriptive statistics. The primary outcomes assessed were postoperative urinary continence, rate of biochemical recurrence, and sexual function.
UNASSIGNED: All procedures were performed without extra ports or conversion. The median age was 62.1 years and 49.0% of the patients had abdominal surgery history. The preoperative median prostate-specific antigen value and prostate volume were 5.0 ng/mL and 33.0 mL, respectively. There were no intraoperative complications. The median operative time and estimated blood loss were 212.5 min and 100.0 mL, respectively. A total of 92.0% of patients were discharged within 24.0 h, with an overall median length of stay of 5.6 h. Only 4.0% of patients required opioid prescriptions at discharge. The median Foley catheter duration was 3 days. Positive margins were present in 15.0% of cases. Median follow-up was 10.4 months. Continence rate was immediate after Foley removal in 49.0% of cases, 65.0% at 2 weeks, 77.4% at 6 weeks, 94.1% at 6 months, and 98.9% at 1 year. One case of biochemical recurrence (1.0%) was noted 3 months after surgery.
UNASSIGNED: The SP TV approach for radical prostatectomy cases is a safe and feasible technique for patients with clinically localized prostate cancer. This technique offers advantages of short hospital stay, minimal narcotic use postoperatively, and promising early return of urinary continence, without compromising oncologic outcomes.
UNASSIGNED: All procedures were performed at a single center by one surgeon. We identified the first 100 consecutive patients with clinically localized prostate cancer that underwent SP TV robot-assisted radical prostatectomy using the da Vinci SP robotic surgical system. Data were collected prospectively and analyzed with descriptive statistics. The primary outcomes assessed were postoperative urinary continence, rate of biochemical recurrence, and sexual function.
UNASSIGNED: All procedures were performed without extra ports or conversion. The median age was 62.1 years and 49.0% of the patients had abdominal surgery history. The preoperative median prostate-specific antigen value and prostate volume were 5.0 ng/mL and 33.0 mL, respectively. There were no intraoperative complications. The median operative time and estimated blood loss were 212.5 min and 100.0 mL, respectively. A total of 92.0% of patients were discharged within 24.0 h, with an overall median length of stay of 5.6 h. Only 4.0% of patients required opioid prescriptions at discharge. The median Foley catheter duration was 3 days. Positive margins were present in 15.0% of cases. Median follow-up was 10.4 months. Continence rate was immediate after Foley removal in 49.0% of cases, 65.0% at 2 weeks, 77.4% at 6 weeks, 94.1% at 6 months, and 98.9% at 1 year. One case of biochemical recurrence (1.0%) was noted 3 months after surgery.
UNASSIGNED: The SP TV approach for radical prostatectomy cases is a safe and feasible technique for patients with clinically localized prostate cancer. This technique offers advantages of short hospital stay, minimal narcotic use postoperatively, and promising early return of urinary continence, without compromising oncologic outcomes.
摘要：
■描述手术技术并报告经膀胱（TV）方法进行单端口（SP）机器人辅助的根治性前列腺切除术的早期结果。
■所有手术均由一名外科医生在一个中心进行。我们确定了使用达芬奇SP机器人手术系统进行SPTV机器人辅助根治性前列腺切除术的前100例临床局限性前列腺癌患者。前瞻性收集数据并进行描述性统计分析。评估的主要结果是术后尿失禁，生化复发率，和性功能。
■在没有额外端口或转换的情况下执行所有程序。中位年龄为62.1岁，49.0%的患者有腹部手术史。术前前列腺特异性抗原值和前列腺体积中位数分别为5.0ng/mL和33.0mL，分别。术中无并发症。中位手术时间和估计失血量分别为212.5min和100.0mL，分别。共有92.0%的患者在24.0h内出院,总体中位住院时间为5.6小时。出院时只有4.0%的患者需要阿片类药物处方。Foley导管的中位持续时间为3天。15.0%的病例存在阳性切缘。中位随访时间为10.4个月。在49.0%的病例中，Foley去除后立即出现延续率，2周时65.0%,6周时77.4%,6个月时94.1%，和98.9%在1年。术后3个月生化复发1例(1.0%)。
■用于根治性前列腺切除术病例的SPTV方法对于临床局限性前列腺癌患者是一种安全可行的技术。这种技术具有住院时间短的优点，术后最少使用麻醉剂，并有望早日恢复尿失禁，在不影响肿瘤学结果的情况下。
■所有手术均由一名外科医生在一个中心进行。我们确定了使用达芬奇SP机器人手术系统进行SPTV机器人辅助根治性前列腺切除术的前100例临床局限性前列腺癌患者。前瞻性收集数据并进行描述性统计分析。评估的主要结果是术后尿失禁，生化复发率，和性功能。
■在没有额外端口或转换的情况下执行所有程序。中位年龄为62.1岁，49.0%的患者有腹部手术史。术前前列腺特异性抗原值和前列腺体积中位数分别为5.0ng/mL和33.0mL，分别。术中无并发症。中位手术时间和估计失血量分别为212.5min和100.0mL，分别。共有92.0%的患者在24.0h内出院,总体中位住院时间为5.6小时。出院时只有4.0%的患者需要阿片类药物处方。Foley导管的中位持续时间为3天。15.0%的病例存在阳性切缘。中位随访时间为10.4个月。在49.0%的病例中，Foley去除后立即出现延续率，2周时65.0%,6周时77.4%,6个月时94.1%，和98.9%在1年。术后3个月生化复发1例(1.0%)。
■用于根治性前列腺切除术病例的SPTV方法对于临床局限性前列腺癌患者是一种安全可行的技术。这种技术具有住院时间短的优点，术后最少使用麻醉剂，并有望早日恢复尿失禁，在不影响肿瘤学结果的情况下。
